Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
4.360
+0.300 (7.39%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Nephros Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Nephros stock has a consensus rating of "Buy" and an average price target of $6.25. The average 1-year stock price forecast is 43.35% higher than the current stock price, while the lowest is $4.75 (+8.94%) and the highest is $8.00 (+83.49%).
Price Target: $6.25 (+43.35%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nephros stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Mar '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 1 |
| Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Northland Securities | Northland Securities | Hold Maintains $4 → $4.75 | Hold | Maintains | $4 → $4.75 | +8.94% | Aug 13, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $8 | Buy | Reiterates | $8 | +83.49% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
22.14M
from 18.79M
Increased by 17.81%
Revenue Next Year
25.66M
from 22.14M
Increased by 15.90%
EPS This Year
0.17
from 0.11
Increased by 54.55%
EPS Next Year
0.21
from 0.17
Increased by 23.53%
EPS and Forward PE are based on non-GAAP adjusted numbers.